Sezaby (phenobarbital) is an injectable medication approved in November 2022 to help treat active seizures in newborns that happen within the first 4 weeks of life. It's typically given in the neonatal intensive care unit (NICU) in the hospital by a healthcare provider. Sezaby (phenobarbital) doesn't contain harmful preservatives or inactive ingredients, making it a safe treatment option for newborns.
Seizures in newborns (neonatal seizures)
Sezaby (phenobarbital) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
When Sezaby (phenobarbital) is given with opioids (strong medications for pain or sedation), there's a risk of severe and potentially life-threatening side effects. These side effects include extreme sleepiness, slowed breathing, coma, or even death. The care team will only use this combination of medications if it's clearly needed and for the shortest amount of time possible. If your baby needs to take Sezaby (phenobarbital) and an opioid at the same time, the care team will carefully look for breathing problems and excessive sleepiness while caring for your baby. Look for these signs as well when you spend time with your baby at the bedside, and call for help right away if you do.
Risk factors: Taking Sezaby (phenobarbital) with medications that cause slowed breathing
Sezaby (phenobarbital) can potentially cause breathing problems in your baby. Your baby's risk is higher if they're receiving Sezaby (phenobarbital) with other medications that have a slowing or calming effect on the body, such as sedatives and opioids. In some cases, slowed breathing can be life-threatening. Let the care team know if your baby's taking any other medications so they can check for potentially dangerous interactions. They'll closely monitor your baby's breathing while getting treated.
Severe allergic reactions to Sezaby (phenobarbital) are possible, including rash, fever, and swelling. Additionally, Sezaby (phenobarbital) can cause serious skin reactions like Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and DRESS syndrome. These reactions can appear as severe rash, fever, skin reddening, blisters, skin peeling, or facial swelling. Finally, reactions like pain or swelling can happen near the area where Sezaby (phenobarbital) is infused. The care team will watch your baby for any of these severe reactions. If they occur, they'll likely stop Sezaby (phenobarbital). Let them know right away if you notice any of these symptoms in your baby.
Risk factors: History of heart problems, slow heart rate, or other abnormal heart rhythms (arrhythmias) | Uncontrolled hypothyroidism (low thyroid hormone) | Abnormal electrolytes | Taking other medications that cause QT prolongation
Sezaby (phenobarbital) can affect your baby's heart rhythm, which can be serious and life-threatening. One example includes affecting the time it takes for the heart to pump and then relax. This is known as QT prolongation. Your baby's risk for QT prolongation is higher if they have certain factors, including abnormal electrolyte levels and heart rhythm problems, among others. The care team will closely monitor your baby's heart rate and heart rhythm while using the medication.
Use in newborns with porphyria
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (1982). Neonatal deaths associated with use of benzyl alcohol -- United States. Morbidity and Mortality Weekly Report.
Krawiec, C., et al. (2023). Neonatal seizure. StatPearls.
Lewis, C. B., et al. (2022). Phenobarbital. StatPearls.
Lim, T. Y., et al. (2014). Propylene glycol toxicity in children. The Journal of Pediatric Pharmacology and Therapeutics.
National Child and Maternal Health Education Program. (2022). Know your terms: Full-term pregnancy.
National Institute of Diabetes and Digestive and Kidney Diseases. (2020). Porphyria.
Sun Pharmaceutical Industries, Inc. (2022). Sezaby (phenobarbital sodium) for injection, for intravenous use, CIV [package insert].
Sun Pharmaceutical Industries Limited. (2022). Sezaby (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures. Reuters.
World Health Organization. (2011). Guidelines on neonatal seizures.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.